Net Cash Provided by (Used in) Operating Activities |
-61K |
USD |
+19.7% |
Oct 31, 2023 |
Q3 2023 |
Net Cash Provided by (Used in) Financing Activities |
200K |
USD |
+33.3% |
Oct 31, 2023 |
Q3 2023 |
Common Stock, Shares Authorized |
400M |
shares |
0% |
Jan 31, 2024 |
Q4 2023 |
Common Stock, Shares, Issued |
155M |
shares |
0% |
Jan 31, 2024 |
Q4 2023 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Jan 31, 2024 |
Q4 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
139K |
USD |
+87.8% |
Oct 31, 2023 |
Q3 2023 |
Deferred Tax Assets, Valuation Allowance |
3.79M |
USD |
-7.63% |
Jul 31, 2023 |
Q2 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Jul 31, 2023 |
Q2 2023 |
Deferred Tax Assets, Gross |
3.79M |
USD |
-7.63% |
Jul 31, 2023 |
Q2 2023 |
Preferred Stock, Shares Issued |
100 |
shares |
0% |
Jul 31, 2022 |
Q2 2022 |
Preferred Stock, Shares Authorized |
100 |
shares |
0% |
Jul 31, 2022 |
Q2 2022 |
Additional Paid in Capital |
26.6M |
USD |
0% |
Jan 31, 2024 |
Q4 2023 |
Preferred Stock, Shares Outstanding |
100 |
shares |
0% |
Jul 31, 2022 |
Q2 2022 |
Interest Expense |
43K |
USD |
+95.5% |
Jan 31, 2024 |
Q4 2023 |
Preferred Stock, Par or Stated Value Per Share |
1 |
USD/shares |
0% |
Jul 31, 2022 |
Q2 2022 |